FGC
NVO

Financial Gravity Companies’s Novo Nordisk NVO Stock Holding History

Financial Gravity Companies’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$2.04M Buy
+29,546
New +$2.01M 0.4% 65
2024
Q4 		$1.92M Buy
22,321
+2,051
+10% +$222K 0.44% 56
2024
Q3 		$2.41M Buy
+20,270
New +$2.7M 0.65% 34
2018
Q4 		$5K Buy
+220
New +$4.89K ﹤0.01% 718
2018
Q1 		$6K Sell
238
-92
-28% -$2.42K 0.01% 682
2017
Q4 		$9K Buy
+330
New +$8.39K 0.01% 585

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Financial Gravity Companies's NVO Position: Q2 2025 in Review

Financial Gravity Companies opened a new position in Novo Nordisk (NVO) in Q2 2025: 29,546 shares worth $2.04M. The stake represents 0.4% of the portfolio and ranks #65 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in NVO as recently as Q4 2024.

Financial Gravity Companies first reported a position in NVO in Q4 2017 and has held it in 6 quarters since. The position peaked at $2.41M in Q3 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Financial Gravity Companies held 29,546 shares of Novo Nordisk worth $2.04M as of Q2 2025.
  • Novo Nordisk was a new Financial Gravity Companies position in Q2 2025.
  • Novo Nordisk made up 0.4% of Financial Gravity Companies's portfolio in Q2 2025, its #65 holding.
  • Financial Gravity Companies first reported a position in Novo Nordisk in Q4 2017 and has held it in 6 quarters since.
  • Financial Gravity Companies's Novo Nordisk position peaked at $2.41M in Q3 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Financial Gravity Companies's 13F filing for Q2 2025, filed 8 Aug 2025.